Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Animals
3.3. Snippet by End User
3.4. Snippet by Country
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in Pet Adoption, Mostly by Nuclear Families
4.1.1.2. Advanced Technology in Animal Healthcare Increasing Patient Awareness
4.1.2. Restraints
4.1.2.1. Use of Counterfeit Medicines in the Country
4.1.3. Opportunity
4.1.3.1. Rising Initiatives by the Government and Animal Welfare Associations
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Diagnostic tests*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Immunodiagnostic Tests
7.2.4. Molecular Diagnostics
7.2.5. Diagnostic Imaging
7.2.6. Others
7.3. Therapeutics
7.3.1. Vaccines
7.3.2. Parasiticides
7.3.3. Anti-Infectives
7.3.4. Medicinal Feed Additives
7.3.5. Others
8. By Animals
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animals
8.1.2. Market Attractiveness Index, By Animals
8.2. Dogs *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cats
8.4. Horses
8.5. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Veterinary Hospitals & Clinics *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Homecare
9.4. Others
10. By Country
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.1.2. Market Attractiveness Index, By Country
10.2. China
10.2.1. Introduction
10.2.2. Key Country-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animals
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Boehringer Ingelheim International GmbH *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Vetoquinol
12.3. Zoetis Services LLC
12.4. Elanco
12.5. MSD Animal Health China (Merck & Co. Inc.)
12.6. China Animal Husbandry Group
12.7. Virbac
12.8. Jinyu Bio-technology Co., Ltd.
12.9. Ceva
12.10. Bimeda, Inc.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us